NCT03270228

Brief Summary

The investigators want to determine the incidence of malignant disease, type of malignant disease and overall survival in patients diagnosed with NSP after VATS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2018

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2019

Completed
Last Updated

December 17, 2020

Status Verified

December 1, 2020

Enrollment Period

4 months

First QC Date

August 30, 2017

Last Update Submit

December 15, 2020

Conditions

Pleural Effusion Due to Another Disorder (Disorder)

Keywords

Incidence of cancerSurvival

Outcome Measures

Primary Outcomes (1)

  • Incidence of cancer

    Percentage

    10 years

Secondary Outcomes (2)

  • Type of cancer

    10 years

  • Survival of patients

    10 years

Interventions

Nonspecific pleuritis after VATS thoracoscopyOTHER

Patients with a pleural effusion with unknown origin after a VATS thoracoscopy is classified as nonspecific pleuritis.

Eligibility Criteria

Age16 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients with a VATS thoracoscopy

You may qualify if:

  • All patients with a VATS thoracoscopy

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Naestved Hospital

Næstved, 4700, Denmark

Location

Study Officials

  • Simon Reuter, MD, PhD

    Naestved Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.d.-Student

Study Record Dates

First Submitted

August 30, 2017

First Posted

September 1, 2017

Study Start

October 1, 2017

Primary Completion

January 31, 2018

Study Completion

January 30, 2019

Last Updated

December 17, 2020

Record last verified: 2020-12

Locations

DK(1)